Anchoring flap suture technique to repair a wound with exposed bone after hip disarticulation: a case report and brief review of the literature.

BACKGROUND: In specific clinical scenarios characterized by poor tissue conditions surrounding a wound, achieving stable flap fixation with standard sutures can be challenging. The anchoring flap suture technique, which is commonly used for soft tissue-to-bone attachment in cases of injury, may be an alternative and effective approach. CASE REPORT: This report describes the successful application of the anchoring flap suture technique to repair a wound with exposed bone in a 39-year-old female patient. She presented with a 7% TBSA wound of the left trunk following hip disarticulation. After 4 operations, a wound with exposed iliac bone remained. Given the compromised condition of the tissues surrounding the exposed bone, the authors opted to anchor a local flap directly to the exposed bone. Steady flap fixation was achieved using the anchoring flap suture method, resulting in complete healing of that wound. Remarkably, no short- or long-term complications associated with the flap were observed. Three months after hospital discharge, the patient regained mobility, walking on 1 leg with the assistance of a 4-legged walker. CONCLUSION: The anchoring flap suture technique seems to be a reliable and effective treatment option, particularly in cases in which inadequate soft tissue precludes the use of traditional flap fixation using standard sutures.

Within-patient randomised clinical trial exploring the development of microskin implantation in the treatment of pressure ulcers.

Pressure injury often seriously affects the life quality of aged patients, especially the long-term bedridden casualties. Widely adopted by different disciplines, negative pressure suction has its role in pressure injury. Microskin implantation has been demonstrated powerful in increasing the expansion ratio of donor area-derived skin and accelerating wound healing by forming "skin islands". The study was designed to evaluate the efficacy and safety of additional use of bedside microskin implantation in the palliative care of pressure injury of aged patients who cannot tolerate surgical treatment as a supplement for standard negative pressure suction. An open-label within-patient RCT was conducted in aged patients with pressure injury. Sixteen patients were enrolled. After granulation tissues formed, half of a pressure injury was randomised to receive the negative pressure suction as the control group, and the other half exposed to additional bedside microskin implantation as the experimental group. Efficacy was evaluated within 1 month after treatment, and the primary endpoints included the wound healing rate and pressure ulcer scale for healing (PUSH) scores. The secondary outcomes included survival rate of implanted microskin, pain intensity assessment, satisfaction surveys from patients or their family, and pressure ulcer healing complications. Sixteen patients completed the study. After 14 days of operation, 5.63 ± 1.78 out of 10 pieces of implanted microskin survived and formed neonatal epithelium. The wound healing rates of the control group and the experimental group at 1 month were (26.17 ± 9.03%) and (35.95 ± 16.02%), respectively (P < .01). The mean PUSH score before the surgery was 12.38 ± 2.23. At 1 month after surgery, the mean difference of PUSH score from baseline was 2.13 ± 0.96 in the control group and 2.81 ± 0.83 in the experimental group (P < .01). The treatment of microskin implantation did not cause additional pain or complications to the patients. Accompanied by a better ulcer status, the majority of patients or their guardians have a high degree of acceptance towards the microskin implantation. Bedside microskin implantation could accelerate wound healing with lower PUSH scores. As a complementary palliative treatment, supplementary microskin implantation is effective and well tolerated.

Wound repair using discarded skin tissue from the rolled edge of pressure injury: a feasibility study of five cases.

INTRODUCTION: New techniques are needed to manage chronic wounds in patients with contraindications to standard of care treatment. OBJECTIVE: This case series investigated the viability and proliferative activity of split skin cells harvested from the discarded rolled edge of PIs for use in promoting reepithelialization in chronic wounds. MATERIALS AND METHODS: The harvested skin was minced into particles with a scalpel. The structure of the skin particle was shown with hematoxylin-eosin staining. The viability of cells, isolated from skin particles, was identified with MTT. Skin particles were transferred to PIs. The size of PI was recorded before grafting and 1 month after grafting. RESULTS: From January 2018 to January 2019, 5 patients (1 female, 4 males; mean age, 72.6 years ± 6.1) were enrolled in this study. The mean ulcer size was 27.8 cm2 ± 17.7. The cells from particles could survive and be amplified in vitro. One month after grafting, the average ulcer size was 16.2 cm2 ± 7.3. CONCLUSION: The split skin particles harvested from the rolled edge of the wound consisted of keratinocytes and keratinized tissues and were found to be viable and proliferative. These particles had the capacity to survive and expand on the granulation tissue surface of PIs, which indicates this procedure could accelerate reepithelization in chronic wounds.

Modified tumescent superficial suction with curettage treatment for axillary bromidrosis: clinical experience of 280 cases.

BACKGROUND: Axillary bromidrosis adversely affects patients' social and personal life with excessive malodor. Although surgical resection of the apocrine glands is one effective and irreversible method for treating axillary bromidrosis, the postoperation complications cannot be ignored. This study aimed to evaluate the long-term outcome of the authors' modified tumescent superficial suction with a curettage procedure for axillary bromidrosis treatment. METHODS: From January 2010 to December 2012, 450 patients with axillary bromidrosis visited the authors' plastic surgery outpatient department and received the modified treated using tumescent superficial suction with a curettage procedure. A total of 170 patients were lost to follow-up evaluation and eliminated from this study. RESULTS: The follow-up period ranged from 5 to 35 months (mean 15.5 months). Among 280 patients, 261 (93.2 %) showed excellent to good results. Reoperation with the same procedure was performed for 15 patients, and all had excellent results afterward. The most common postoperative complication was transient ecchymosis (23.6 %). CONCLUSION: The modified suction and curettage procedure is an optimal therapeutic strategy for axillary bromidrosis treatment. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .